Mutlu, N. Et Al. 2009. Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range.. The Canadian journal of urology , vol.16, no.2 , 4558-67.

Mutlu, N., Türkeri, L., Yencilek, F., Demir, A., & Emerk, K., (2009). Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range.. The Canadian journal of urology , vol.16, no.2, 4558-67.

Mutlu, Nilgun Et Al. "Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range.," The Canadian journal of urology , vol.16, no.2, 4558-67, 2009

Mutlu, Nilgun Et Al. "Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range.." The Canadian journal of urology , vol.16, no.2, pp.4558-67, 2009

Mutlu, N. Et Al. (2009) . "Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range.." The Canadian journal of urology , vol.16, no.2, pp.4558-67.

@article{article, author={Nilgun Mutlu Et Al. }, title={Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range.}, journal={The Canadian journal of urology}, year=2009, pages={4558-67} }